MicroRNA Control of Invasion and Metastasis Pathways

Despite recent advances, cancer remains a leading cause of death worldwide. In developed countries, the incidence of colorectal and breast cancer has been stable, but no improvement in prognosis has been observed if the patient presents with metastases at diagnosis. This fact highlights the importan...

Full description

Bibliographic Details
Main Authors: Sreekumar, Rahul, Sayan, Berna S., Mirnezami, Alex H., Sayan, A. Emre
Format: Online
Language:English
Published: Frontiers Research Foundation 2011
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3268611/
id pubmed-3268611
recordtype oai_dc
spelling pubmed-32686112012-02-02 MicroRNA Control of Invasion and Metastasis Pathways Sreekumar, Rahul Sayan, Berna S. Mirnezami, Alex H. Sayan, A. Emre Genetics Despite recent advances, cancer remains a leading cause of death worldwide. In developed countries, the incidence of colorectal and breast cancer has been stable, but no improvement in prognosis has been observed if the patient presents with metastases at diagnosis. This fact highlights the importance of therapeutic approaches targeting cellular invasion and metastasis programs as the next step in cancer treatment. During carcinoma progression a process called epithelial–mesenchymal transition (EMT) results in enhanced invasion and motility which is directly linked with loss of epithelial polarity and epithelial junctions, migration permissive cytoskeleton alterations, and the acquisition of mesenchymal properties. The recent discovery of microRNAs (miRNAs) controlling key cellular pathways has opened a new era in understanding how EMT pathways are modulated. In this review, we classify EMT regulating proteins according to their cellular localization (membrane, cytoplasmic, and nuclear), and summarize the current knowledge on how they are controlled by miRNAs and propose potential miRNAs for the transcripts that may control their expression. Frontiers Research Foundation 2011-09-05 /pmc/articles/PMC3268611/ /pubmed/22303353 http://dx.doi.org/10.3389/fgene.2011.00058 Text en Copyright © 2011 Sreekumar, Sayan, Mirnezami and Sayan. http://www.frontiersin.org/licenseagreement This is an open-access article subject to a non-exclusive license between the authors and Frontiers Media SA, which permits use, distribution and reproduction in other forums, provided the original authors and source are credited and other Frontiers conditions are complied with.
repository_type Open Access Journal
institution_category Foreign Institution
institution US National Center for Biotechnology Information
building NCBI PubMed
collection Online Access
language English
format Online
author Sreekumar, Rahul
Sayan, Berna S.
Mirnezami, Alex H.
Sayan, A. Emre
spellingShingle Sreekumar, Rahul
Sayan, Berna S.
Mirnezami, Alex H.
Sayan, A. Emre
MicroRNA Control of Invasion and Metastasis Pathways
author_facet Sreekumar, Rahul
Sayan, Berna S.
Mirnezami, Alex H.
Sayan, A. Emre
author_sort Sreekumar, Rahul
title MicroRNA Control of Invasion and Metastasis Pathways
title_short MicroRNA Control of Invasion and Metastasis Pathways
title_full MicroRNA Control of Invasion and Metastasis Pathways
title_fullStr MicroRNA Control of Invasion and Metastasis Pathways
title_full_unstemmed MicroRNA Control of Invasion and Metastasis Pathways
title_sort microrna control of invasion and metastasis pathways
description Despite recent advances, cancer remains a leading cause of death worldwide. In developed countries, the incidence of colorectal and breast cancer has been stable, but no improvement in prognosis has been observed if the patient presents with metastases at diagnosis. This fact highlights the importance of therapeutic approaches targeting cellular invasion and metastasis programs as the next step in cancer treatment. During carcinoma progression a process called epithelial–mesenchymal transition (EMT) results in enhanced invasion and motility which is directly linked with loss of epithelial polarity and epithelial junctions, migration permissive cytoskeleton alterations, and the acquisition of mesenchymal properties. The recent discovery of microRNAs (miRNAs) controlling key cellular pathways has opened a new era in understanding how EMT pathways are modulated. In this review, we classify EMT regulating proteins according to their cellular localization (membrane, cytoplasmic, and nuclear), and summarize the current knowledge on how they are controlled by miRNAs and propose potential miRNAs for the transcripts that may control their expression.
publisher Frontiers Research Foundation
publishDate 2011
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3268611/
_version_ 1611502784613449728